Literature DB >> 20600373

The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia.

Eiji Kitamura1, Junichi Hamada, Naomi Kanazawa, Junko Yonekura, Ray Masuda, Fumihiko Sakai, Hideki Mochizuki.   

Abstract

Orexin-A is a neuropeptide involved in the control feeding, arousal or sleep behavior in the hypothalamus. In the present study, the cortex and lateral hypothalamus of rats subjected to middle cerebral artery occlusion (MCAO)-reperfusion brain injury were examined by double immunofluorescence staining. The number of orexin-A-expressing neurons in the non-ischemic side was significantly lower than the ischemic side. Next, orexin-A was administered intracerebroventricularly followed by the induction of MCAO-reperfusion injury. Administration of orexin-A at 0.3nmol significantly reduced the brain infarct area. The results suggested that orexin-A alters the pathological mechanisms involved in brain ischemia and has a neuroprotective effect. 2010 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600373     DOI: 10.1016/j.neures.2010.06.010

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  22 in total

1.  More Wake, Less Stroke.

Authors:  Matteo Cerri
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

2.  Recovery from Coma Post-Cardiac Arrest Is Dependent on the Orexin Pathway.

Authors:  Young-Jin Kang; Guilian Tian; Afsheen Bazrafkan; Maryam H Farahabadi; Matine Azadian; Hamidreza Abbasi; Brittany E Shamaoun; Oswald Steward; Yama Akbari
Journal:  J Neurotrauma       Date:  2017-06-16       Impact factor: 5.269

3.  Identification of Sleep-Modulated Pathways Involved in Neuroprotection from Stroke.

Authors:  Marta Pace; Francesca Baracchi; Bo Gao; Claudio Bassetti
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

Review 4.  Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy.

Authors:  Piyush Madaan; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Shivam Yadav; Satvinder Kaur; Saurabh Bhatia; Ahmed Al-Harrasi; Ahmed A H Abdellatif; Ghulam Md Ashraf; Mohamed M Abdel-Daim; Hamad Ghaleb Dailah; Md Khalid Anwer; Simona Bungau
Journal:  Neurotox Res       Date:  2022-01-26       Impact factor: 3.911

5.  Mitigation of murine focal cerebral ischemia by the hypocretin/orexin system is associated with reduced inflammation.

Authors:  Xiaoxing Xiong; Robin E White; Lijun Xu; Liya Yang; Xiaoyun Sun; Bende Zou; Conrado Pascual; Takeshi Sakurai; Rona G Giffard; Xinmin Simon Xie
Journal:  Stroke       Date:  2013-01-24       Impact factor: 7.914

Review 6.  Intranasal insulin and orexins to treat age-related cognitive decline.

Authors:  Jennifer M Erichsen; Coleman B Calva; Lawrence P Reagan; Jim R Fadel
Journal:  Physiol Behav       Date:  2021-02-21

7.  Method parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis.

Authors:  Jakob O Ström; Edvin Ingberg; Annette Theodorsson; Elvar Theodorsson
Journal:  BMC Neurosci       Date:  2013-04-01       Impact factor: 3.288

Review 8.  The role of orexin in post-stroke inflammation, cognitive decline, and depression.

Authors:  Juhyun Song; Eosu Kim; Chul-Hoon Kim; Ho-Taek Song; Jong Eun Lee
Journal:  Mol Brain       Date:  2015-03-11       Impact factor: 4.041

9.  Involvement of Heme Oxygenase-1 in Orexin-A-induced Angiogenesis in Vascular Endothelial Cells.

Authors:  Mi-Kyoung Kim; Hyun-Joo Park; Su-Ryun Kim; Yoon Kyung Choi; Soo-Kyung Bae; Moon-Kyoung Bae
Journal:  Korean J Physiol Pharmacol       Date:  2015-06-30       Impact factor: 2.016

10.  Orexins protect neuronal cell cultures against hypoxic stress: an involvement of Akt signaling.

Authors:  Paulina Sokołowska; Anna Urbańska; Kaja Biegańska; Waldemar Wagner; Wojciech Ciszewski; Magdalena Namiecińska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2013-11-19       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.